Browsing Tag
Z-1018
2 posts
Sanofi bets $2.2bn on Dynavax to expand adult vaccine pipeline with hepatitis B and shingles focus
Find out how Sanofi’s $2.2B Dynavax buyout could reshape its adult vaccine strategy with HEPLISAV-B and a new shingles candidate in development.
Dynavax begins clinical trial for new shingles vaccine candidate, Z-1018
Dynavax Technologies Corporation, a renowned player in the biopharmaceutical sector, has made headlines with the initiation of a…